Form 4: Intuitive Surgical SVP Mark Brosius Executes Stock Option and Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark Brosius, SVP & Chief Manufacturing and Supply Chain Officer at Intuitive Surgical, exercised stock options and disposed of shares to cover tax withholding requirements on February 10, 2025.
Summary
- On February 10, 2025, Mark Brosius, SVP & Chief Manufacturing and Supply Chain Officer at Intuitive Surgical Inc. (ISRG), executed stock options and disposed of shares.
- He acquired 838 shares of common stock through the vesting of Restricted Stock Units (RSUs) at a price of $0.0.
- He then disposed of 430 shares of common stock at a price of $582.98 to cover statutory tax withholding requirements.
- Following these transactions, Brosius directly owns 648 shares of common stock and 1,676 Restricted Stock Units.
- The RSUs vest 25% per year over a four-year period, commencing on each anniversary of February 10, 2023, and convert into common stock on a one-for-one basis upon vesting.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard insider transaction related to stock options and tax obligations, with no indication of positive or negative sentiment towards the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and is a common occurrence for publicly traded companies like Intuitive Surgical. It provides transparency into the trading activities of company executives.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their executives, ensuring transparency in insider trading activities.
- Similar filings are regularly made by executives at comparable companies in the medical device industry, such as Medtronic, Stryker, and Johnson & Johnson, when they exercise stock options or dispose of shares.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- Shareholders may view insider transactions as a signal of management's confidence (or lack thereof) in the company, but this particular transaction appears routine and related to compensation.
Key Dates
| Date | Description |
|---|---|
| 02/28/2023 | Date of the Restricted Stock Units |
| 02/10/2023 | Commencement date for RSU vesting (25% per year over four years). |
| 02/10/2025 | Date of the reported transactions: RSU vesting and share disposal. |
Keywords
Form 4, Intuitive Surgical, ISRG, Mark Brosius, Restricted Stock Units, RSUs, Stock Options, Beneficial Ownership, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.